Risk factors of prostate cancer: a case- control study in Northeast Brazil

Authors

DOI:

https://doi.org/10.17765/2176-9206.2022v15n1.e10072

Keywords:

Prostate cancer, Risk factors, African continental ancestry group, Tobacco use disorder, Family health history

Abstract

Este estudo caso-controle teve como objetivo identificar os fatores que modificam o risco de câncer de próstata em pacientes de um hospital público da Paraíba. Dados de 91 pacientes e 91 controles saudáveis pareados por idade (± 5 anos) foram obtidos de prontuários médicos e entrevistas pessoais. A razão de chance e os intervalos de confiança foram determinados por meio de análise de regressão. Pacientes e controles tinham em média 69,56 (DP = 8,31) e 68,32 (DP = 7,68) anos (p = 0,297). Afrodescendentes e homens que já fumaram, tiveram um risco 4,150 e 3,939 vezes maior (p <0,001; p <0,001). A história familiar aumentou o risco 6,967 vezes (p <0,001). Ascendência africana, tabagismo e história familiar aumentaram o risco de câncer de próstata. As recomendações das autoridades de saúde em relação ao rastreamento do câncer de próstata poderiam se concentrar mais nos homens com esses fatores de risco.

Downloads

Download data is not yet available.

Author Biographies

Eduardo, Universidade Estadual da Paraíba - UEPB

Master’s degree in the Program of Public Health, State University of Paraíba (UEPB), Campina Grande, Paraíba, Brazil.

Mathias Weller, Universidade Estadual da Paraíba - UEPB

Professor Associado no Programa de Pós-Graduação em Saúde Publica, Universidade Estadual da Paraíba (UEPB), Campina Grande (PB), Brasil.

References

1. Ferlay J EM, Lam F, Colombet M, Mery L, Pineros M, Znaor A, Soerjomataram I, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc. Accessed 2nd February 2021.

2. Instituto Nacional de Câncer (INCA, 2020). Estimativa 2020: Incidência de câncer no Brasil. Disponível: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil.

3. Instituto Nacional de Câncer (INCA, 2005). Estimativa 2005: Incidência de câncer no Brasil. Disponível: http://www1.inca.gov.br/vigilancia/docs/portugal2005/estimativa%202005.pdf

4. Salzano FM and M. Sans. Interethnic admixture and the evolution of Latin American populations. Genet Mol Biol 2014; 37:151–70. http://doi.org/10.1590/S1415-47572014000200003.

5. Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Altekruse S et al. SEER Cancer Statistics Review 1975–2013. National Cancer Institute, Bethesda, MD 2016; (seer.cancer .gov/csr/1975_2013).

6. Panigrahi GK, Praharaj PP, Kittaka H, Mridha AR, Black OM, Singh R, et al. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Med 2019; 8(3):1110-23. doi: 10.1002/cam4.1885.

7. Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002; 11: 1638–44.

8. Brandt A, Sundquist J, Hemminki K. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncol 2011; 23:251–6.

9. Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M et al. Height and prostate cancer risk: A large nested case control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 2325–36.

10. Möller E, Wilson KM, Batista JL, Mucci LA, Bälter K, Giovannucci E. 2016. Body size across the life course and prostate cancer in the Health Professionals Follow-up Study. Int J Cancer 138: 853–865.

11. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med 2018; 8:a030361.

12. Rawla P. Epidemiology of Prostate Cancer. World J Oncol 2019; 10(2):63-89.

13. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, Lubaroff DM, et al. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 1997; 8(2):229-38.

14. Platz EA and Giovannucci E. Prostate Cancer. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. p. 1128-50.

15. Gonçalves IR, Padovani C, Popim RC. Demographic and epidemiological characterization of men with prostate cancer. Ciência & Saúde Coletiva 2008; 13(4):1337-42.

16. Ribeiro PVF, Silva RR; Dall KK, Santos AT, Loureiro FHF, Furtado P et al. Clinical and Epidemiological Analysis of 348 Cases of Prostate Adenocarcinoma Attended in a Cancer Care Center in Maranhão, Brazil. Rev Bras Canc 2013; 59(4):513-21

17. Zacchi SR, Amorim MHC, Souza MAC, Miotto MHMB, Zandonade E. Association of sociodemographic and clinical variables with initial staging in men with prostate cancer. Cad Saúde Colet 2014; 22(1):93-100.

18. Araújo JS, Conceição VM, Oliveira RAA, Zago MMF. Social and clinical chracteriization of men with prostate cancer treated at a university hospital. Rev Min Enferm 2015; 19(2):204-10. DOI: 10.5935/1415-2762.20150035 br/jun.

19. Silva JFS, Silva AMC, Lima-Luz L, Aydos RD, Mattos IE. Correlation between agricultural production, clinical and demographic variables and prostate cancer: an ecological study. Ciência & Saúde Coletiva 2015; 20(9): 2805-12.

20. Oliveira JS, Ferreira RS, Santos LM, Marin LJ, Corrêa RX, Luizon MR et al. Self-declared ethnicity and genomic ancestry in prostate cancer patients from Brazil. Genet Mol Res 2016; Oct 17:15(4). doi: 10.4238/gmr15048769.

21. Koseki IAY, Benedet MR, Sá G, Conti R, Bernardi RM, Silva AR et al. Prostate cancer profiles and associated factors in Criciúma- Santa Catarina, Brazil. Medicina (Ribeirão Preto. Online) 2019; 52(2):104-9.

22. Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. Br J Cancer 2011; 105(4):481-85.

23. Du Z, Hopp H, Ingles SA, Huff C, Sheng X, Weaver B et al. A genome-wide association study of prostate cancer in Latinos. Int J Cancer 2020; 146:1819–26.

24. Chu LW, Ritchey J, Devesa SS, Quraishi SM, Zhang H, Hsing AW. Prostate cancer incidence rates in Africa. Prostate Cancer 2011; 2011:947870.

25. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J et al. Human prostate cancer risk factors. Cancer 2004;v101(10 Suppl):2371-90.

26. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. 2004;93(8):1139-50.

27. Barber L, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn T et al. Family History of Breast or Prostate Cancer and Prostate Cancer Risk. Clin Cancer Res 2018; 24(23):5910-17. doi: 10.1158/1078-0432.CCR-18-0370.

28. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA 2011; 305: 2548–55.

29. Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, Stampfer MJ, Willett WC. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev. 1999; 8(4 Pt 1):277-82.

Published

2022-01-31

How to Cite

Brito, E. B. N. de ., & Weller, M. (2022). Risk factors of prostate cancer: a case- control study in Northeast Brazil . Saúde E Pesquisa, 15(1), 1–12. https://doi.org/10.17765/2176-9206.2022v15n1.e10072

Issue

Section

Artigos Originais